Mission Bio
Highly Engaged Employees
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
400 E Jamie Ct Ste 100, South San Franci...Phone Number
(415) 854-0058Website
www.missionbio.comRevenue
$19 MillionIndustry
About Mission Bio
Mission Bio Org Chart
Is Mission Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Mission Bio has new funding data
Check if Mission Bio has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Mission Bio
Website visits: Recent activity has been detected on your website
Check out if Mission Bio is spiking on competitors!
Mission Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Mission Bio launches new products
Earning: See what the market has to say on Mission Bio recently announced quarterly report
Click to see if Mission Bio had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Mission Bio
Find 3 more new buyers
Compare Similar Companies to Mission Bio
Compare insights from companies similar to Mission Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Mission Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Mission Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Mission Bio.
Mission Bio financials insights
Gather financial insights about Mission Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Other Financing Round
$1M
Other Financing Round
$6M
Series A
$10M
Series B
$30M
Series C
$70M
Mission Bio Tech Stack
A closer look at the technologies used by Mission Bio
Most Recent Scoops
Mission Bio News & Media
Mission Bio Secures Equity Financing to Accelerate Single-Cell Tri-omics Platform Expansion
SOUTH SAN FRANCISCO, Calif., August 05, 2025--Mission Bio, a leader in single-cell multi-omics solutions for precision medicine, today announced the successful completion of equity financing led by Ally Bridge Group. The investment will fund new innovations, commercial partnerships, and clinical adoption. The company’s vision is to accelerate clinical adoption of the company's Tapestri® Platform across multiple cancer segments by providing crucial insights into treatment decision-making. This efMission Bio Unveils Industry-First Single-Cell Genotype and Targeted Gene Expression Solution Aimed at Derisking Cancer Drug Clinical Development
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mission Bio, a leader in single-cell multi-omics solutions for precision medicine, today announced the launch of its Single-Cell Genotype and Targeted Gene Expression assay, expanding the capabilities of its Tapestri Platform to become the only commercial solution that delivers simultaneous genotype and targeted gene expression profiling from over 10,000 single cells. The assay, which can be leveraged for Phase 2 or 3 trials to home in on patients mMission Bio and Integrated DNA Technologies Partner to Advance Single-Cell Precision in CRISPR Genome Editing Analysis
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mission Bio, a pioneer in single-cell multi-omics solutions, has partnered with Integrated DNA Technologies (IDT), a global leader in genomics solutions, to introduce an advanced workflow for precise on- and off-target confirmation in gene editing applications. This collaboration integrates IDT’s award-winning rhAmpSeq™ technology with Mission Bio’s Tapestri® Platform to provide a comprehensive, high-resolution approach for assessing genome editingMission Bio Showcases Critical Insights Into Multiple Myeloma, AML MRD, CAR-T Safety & Integrated Single-Cell DNA and Fusion Profiling at the 2024 ASH Annual Meeting
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mission Bio, a leader in single-cell multiomics solutions for precision medicine, today announced the full list of presentations by leading researchers and clinicians spanning multiple indications of blood cancer, leveraging the Tapestri Platform to advance therapeutic research and development at the 66th ASH Annual Meeting and Exposition. More than 20 presentations at the event, which takes place Dec. 7-10 in San Diego, will shine a spotlight on ho
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mission Bio
Mission Bio is a biotechnology company specializing in single-cell multi-omics solutions, enabling researchers to analyze DNA, RNA, and proteins at the single-cell level to advance cancer research and cell and gene therapy development.... Read More
